At the Capio Prostate Cancer Center, a new diagnostic process using prostate-specific antigen, Stockholm3, magnetic resonance imaging, and targeted biopsies has been implemented to improve prostate cancer testing and diagnosis in Stockholm, Sweden. The gene discussed is KLK3; the disease is prostate carcinoma.